Akeso Future Growth
Future criteria checks 6/6
Akeso is forecast to grow earnings and revenue by 53.3% and 33.4% per annum respectively. EPS is expected to grow by 54.7% per annum. Return on equity is forecast to be 23.9% in 3 years.
Key information
53.3%
Earnings growth rate
54.7%
EPS growth rate
Biotechs earnings growth | 42.8% |
Revenue growth rate | 33.4% |
Future return on equity | 23.8% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,090 | 1,148 | 1,130 | 1,476 | 21 |
12/31/2025 | 4,061 | 213 | -250 | 313 | 21 |
12/31/2024 | 2,569 | -383 | -892 | -247 | 21 |
6/30/2024 | 1,874 | -735 | -1,499 | -750 | N/A |
3/31/2024 | 3,200 | 646 | 45 | 859 | N/A |
12/31/2023 | 4,526 | 2,028 | 1,588 | 2,468 | N/A |
9/30/2023 | 4,439 | 2,008 | 1,459 | 2,340 | N/A |
6/30/2023 | 4,351 | 1,987 | 1,330 | 2,212 | N/A |
3/31/2023 | 2,595 | 409 | -356 | 486 | N/A |
12/31/2022 | 838 | -1,168 | -2,043 | -1,240 | N/A |
9/30/2022 | 549 | -1,224 | -1,997 | -1,238 | N/A |
6/30/2022 | 260 | -1,280 | -1,952 | -1,235 | N/A |
3/31/2022 | 243 | -1,178 | -1,835 | -1,118 | N/A |
12/31/2021 | 226 | -1,075 | -1,717 | -1,001 | N/A |
9/30/2021 | 177 | -1,002 | -1,525 | -882 | N/A |
6/30/2021 | 129 | -929 | -1,333 | -762 | N/A |
3/31/2021 | 64 | -983 | -1,200 | -690 | N/A |
12/31/2020 | N/A | -1,036 | -1,066 | -618 | N/A |
9/30/2020 | 35 | -870 | -814 | -443 | N/A |
6/30/2020 | 71 | -703 | -562 | -267 | N/A |
3/31/2020 | 71 | -492 | -459 | -243 | N/A |
12/31/2019 | 71 | -282 | -356 | -220 | N/A |
12/31/2018 | 3 | -142 | -198 | -123 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9926 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: 9926 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 9926 is expected to become profitable in the next 3 years.
Revenue vs Market: 9926's revenue (33.4% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 9926's revenue (33.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9926's Return on Equity is forecast to be high in 3 years time (23.9%)